Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.

Suppr

超能文献

作者信息

Navarro F, Miró E, Izquierdo C, Mirelis B, Prats G

出版信息

Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):645-6. doi: 10.1007/BF01973651.

DOI:10.1007/BF01973651

PMID:8223670

Abstract

摘要

相似文献

Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.

Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):645-6. doi: 10.1007/BF01973651.

[Bacterial enteropathogens and antimicrobial resistance in Zamora: the usefulness of fluoroquinolones].

Med Clin (Barc). 1993 Apr 10;100(14):557-9.

Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1.

Antimicrob Agents Chemother. 2007 Jun;51(6):2236-9. doi: 10.1128/AAC.01444-06. Epub 2007 Apr 2.

In vitro activity of sparfloxacin against selected enterobacteriaceae and pseudomonaceae including Ps. pseudomallei (melioidosis).

J Chemother. 1995 Nov;7 Suppl 4:54-5.

Activity of four fluoroquinolones against 346 strains of enteric pathogens.

J Antimicrob Chemother. 1993 Mar;31(3):447-50. doi: 10.1093/jac/31.3.447.

Resistance development to fluoroquinolones in Europe.

Am J Med. 1989 Nov 30;87(5A):9S-11S. doi: 10.1016/0002-9343(89)90011-9.

Prevalence of fluoroquinolone resistance in clinical strains of Campylobacter jejuni isolated in Spain.

J Antimicrob Chemother. 1994 Jan;33(1):188-90. doi: 10.1093/jac/33.1.188.

Cross-resistance and cross-susceptibility between fluoroquinolone agents.

Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1013-8. doi: 10.1007/BF01984922.

Breakpoint determination: rufloxacin.

Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):574-5. doi: 10.1007/BF01970973.

Comparison of E test with conventional agar MICs for quinolones.

J Antimicrob Chemother. 1994 Feb;33(2):356. doi: 10.1093/jac/33.2.356.

引用本文的文献

Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance.

J Clin Microbiol. 1996 Mar;34(3):597-602. doi: 10.1128/jcm.34.3.597-602.1996.

Urinary tract infection caused by quinolone-resistant Campylobacter coli.

Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):690-1. doi: 10.1007/BF01974004.

Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides.

Antimicrob Agents Chemother. 1994 Sep;38(9):1879-82. doi: 10.1128/AAC.38.9.1879.

本文引用的文献

Isoprenoid quinone content and cellular fatty acid composition of Campylobacter species.

J Clin Microbiol. 1984 Jun;19(6):772-6. doi: 10.1128/jcm.19.6.772-776.1984.

Health and economic impacts of antimicrobial resistance.

Rev Infect Dis. 1987 Nov-Dec;9(6):1065-78. doi: 10.1093/clinids/9.6.1065.

Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990.

Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):906-8. doi: 10.1007/BF01967511.

Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

Lancet. 1990 Mar 31;335(8692):787. doi: 10.1016/0140-6736(90)90897-e.

Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):953-7. doi: 10.1007/BF02005451.

Quinolones and Salmonella gastroenteritis.

J Antimicrob Chemother. 1992 Aug;30(2):221-8. doi: 10.1093/jac/30.2.221.

Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.

Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):164-7. doi: 10.1007/BF01967070.

Emerging quinolone resistance in campylobacters.

Lancet. 1992 Jul 25;340(8813):245. doi: 10.1016/0140-6736(92)90517-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验